The Governing Council has been informed about the processing of a Framework Agreement that will facilitate the centralized purchase of these devices. These equipments are crucial for hospitalized patients at high risk of developing thrombosis, a condition involving the formation of blood clots, usually in the legs, which can compromise circulation and pose a life-threatening risk if they travel to vital organs such as the heart or lungs.

Deep vein thrombosis can affect individuals with prolonged immobility, postoperative patients, those in intensive care units, and people with predisposing factors such as a history of the condition, advanced age, or obesity.

This initiative complements other recent acquisitions aimed at strengthening cardiovascular health in the region's public health centers. Recently, another Framework Agreement worth over 100 million euros was processed for the purchase of implantable automatic defibrillators, intended to treat severe cardiac arrhythmias.

Furthermore, the Community of Madrid has used a similar system to equip public healthcare with intracorporeal left ventricular mechanical circulatory assistance, with an investment exceeding 10 million euros, to address advanced heart failure. The centralized purchasing strategy through Framework Agreements ensures a continuous supply of products, minimizes the risk of shortages, and reduces bureaucratic burdens for hospital staff, while also optimizing economic conditions.